Precipitating Factors of Hepatic Encephalopathy
|
|
- Jewel Malone
- 8 years ago
- Views:
Transcription
1 Original Article Precipitating Factors of Hepatic Encephalopathy Mohammad Tariq,* Saleem Iqbal,** Naji ullah Khan,* Rabia Basri*** From Department of Medicine, Khyber Teaching Hospital, Peshawar. *Post Graduate Trainee, **Senior Registrar, *Post Graduate Trainee, ***House Officer Correspondence: Received: Accepted: Dr. Mohammad Tariq, Medical B Unit, Khyber Teaching Hospital Peshawar, Pakistan. Mob: drtariqkhattak@yahoo.com ABSTRACT Objective: To analyze the precipitating factors of hepatic encephalopathy (HE). Methods: Two hundred admitted patients with liver cirrhosis with HE from 1 st January 2006 to 30 th September 2006 were included in the study. Grades of HE and Child s Pugh classification was also determined. Results: Out of 200 patients, 106 (53%) were male and 94 (47%) female. Amongst the precipitating factors, 30% had constipation, 29% upper gastrointestinal bleed (GIB), 8% spontaneous bacterial peritonitis (SBP), 19.5% urinary tract infection (UTI), 2.5% lower respiratory tract infection and 3% had diarrhea. There was hyponatremia in 1.5% and hypokalemia in 4.5% patients. High protein diet in 0.5% and bromazepam intake in 1%
2 were presumed precipitating factors and 0.5% had antituberculous therapy induced liver injury. Conclusion: Constipation, gastrointestinal bleeding and infections were the most common precipitating factors of HE in our patients. (Rawal Med J 2009;34:95-97). Key Words: Hepatic Encephalopathy, liver cirrhosis, precipitating factors, portosystemic encephalopathy. INTRODUCTION Hepatic encephalopathy (HE) is a neuropsychiatric syndrome, which develops due to acute or chronic liver diseases. It is functional in nature and potentially reversible and symptoms range from subtle personality changes to deep coma. 1 Diminished hepatic reserve results in impaired ability of liver to detoxify toxins that are absorbed from the bowel. 2 Accumulation of ammonia, predominantly as a result of poor hepatic function and portosystemic shunting, has traditionally been considered to have an important role in the pathogenesis of HE. 3 The level of ammonia in the arterial blood, however, is poorly correlated with the grade of HE. 4 Most episodes of HE in patients with cirrhosis are due to clinically apparent precipitating factors or the spontaneous development of portosystemic shunting. 3 These factors could be determined in 75.4% of chronic and 97.3% episodes of acute HE. 5 The frequency of risk factors for the
3 development of HE in patients with chronic liver disease was 47% due to infections, 30% due to GIT bleeding, 19% due to constipation, and 4% due to miscellaneous factors. 6 The overall in-hospital mortality was 29% 7 and mean time to come out of HE was hours. 8 HE has been classified into four grades that range from grade I to IV 9 and identification of precipitating factors is helpful, as the neurological deficits are usually completely reversible upon their correction. 10 The aim of this study was to determine the frequency of precipitating factors for the development of HE in patients admitted with liver cirrhosis at our institution. PATIENTS AND METHODS We conducted a descriptive, cross sectional, prospective, single center study on 200 consecutive patients of HE admitted to the medical units of Khyber Teaching Hospital, Peshawar from 1 st January 2006 to September All patients who were 15 years or above in age with HE and liver cirrhosis were included. A detailed clinical history and meticulous physical examination of every patient was done. Diagnosis of HE was made on clinical basis. All relevant investigations including full blood count, urine microscopy, serum electrolytes, blood urea, serum creatinine, blood glucose, sonography and a chest radiograph were done. In the presence of ascites a diagnostic ascitic tap was also done to look for any evidence of spontaneous bacterial peritonitis (SBP).
4 Serum bilirubin, Alanine Aminotransferase (ALT) levels, serum albumin and prothrombin time were also done to help assess their Child-Pugh score. All patients were followed for the duration of their stay in hospital. Data were analyzed using SPSS version RESULTS Out of 200 patients, 106 (53%) were males and 94 (47%) were females. Majority of the patients (67%) were in the age group of years. Only one (0.5%) was below the age of 20 years (Table 1). Table 1. Age-wise distribution of 200 patients with HE. Age (years) Number of patients Percentage % % % % % % % Total % Large percentage had hepatitis C (Fig 1) and majority was in grade I and II HE (Table 2). All patients belonged to Child-Pugh class-b and C (Table 3).
5 Table 2. Grades of Hepatic Encephalopathy (N = 200). Grade of hepatic Number of patients Percentage encephalopathy Grade I % Grade II % Grade III % Grade IV % Amongst the precipitating factors, constipation, gastrointestinal bleed (GIB) and infections were most commonly encountered (Table 4). Table 3. Child-pugh class of Hepatic Encephalopathy (N = 200). Child-Pugh class Number of patients Percentage A 0 0 B % C % None of the patients had history of alcohol intake, recent surgery or shunt procedure.
6 Fig 1. Viral status in 200 patients with hepatic encephalopathy Percent 0 Hepatitis B Virus+ Both B&C Positive Both B&C Negative Hepatitis C Virus+ Viral status Out of these 200 patients, 180 (90%) patients recovered from encephalopathy, six (3%) patients left against medical advice (LAMA) and 14 (7%) patients expired.
7 Table 4. Precipitating factors in 200 patients of Hepatic Encephalopathy and gender of patients (N = 200). Precipitating factor of hepatic encephalopathy Gender of the patients Percent of total patients P value Number of Number of females males Constipation % Upper gastrointestinal bleeding % Urinary tract infection % Spontaneous bacterial peritonitis % Hypokalemia % Diarrhea 5 1 3% Lower respiratory tract infection % Hyponatremia % Sedative intake 0 2 1% Excessive protein intake % Antituberculous therapy induced % DISCUSSION Cirrhosis of liver is one of the common causes of morbidity and mortality world over. 11 HE is a major neuropsychiatric complication of cirrhosis and it s appearance is indicative of a poor prognosis, 12,13 as HE is the commonest cause of death in patients with liver cirrhosis. 14 A clearly defined precipitating factor is usually identified in most patients with HE, and the reversal or control of these factors is a key step in the management. 15 Our study had more male patients with majority of those years old, as reported earlier. Constipation was the commonest factor responsible for 30% cases of HE in our patients, which is close to earlier published studies. 8,15 Constipation probably is the result of lack of consistent use of lactulose by our patients,
8 he. Precipitating factor of HE which may be because of its cost or patients did not find it a good laxative. Infections like SBP, urinary tract infection and lower respiratory tract infection were the 2 nd most common factor present in 30% of cases, as shown to be 28% in another study. 16 GIB was the third most important factor and was found in 29% of patients in our study, which is similar to 30% 6 and 33% 17 reported earlier. This study correlates well to the available national and international data (Table 5). Table 5. Comparison of frequency of different precipitating factors of Shaikh 18 Ahmed 16 Conn 9 Faloon 17 Alam 15 Mahboob 6 Present Study Constipation Diarrhea Gastrointestinal bleed Infections Hypokalemia Hyponatremia Increase protein intake Sedative intake Miscellaneous Figures are percentages. Electrolyte imbalance was found in 12 (6%) patients, consistent with study of Conn et al 9 who reported it in 9%. We found diarrhea in 6 (3%), high protein intake in 1 (0.5%) and sedative intake in 2 (1%) patients, which are similar to studies reported already. 6,9 In conclusion, constipation, gastrointestinal bleeding and infections stand out as the most common precipitating factors of HE in almost all the studies. There is a definite need
9 for health education in patients with cirrhosis regarding the risk of HE and its precipitating factors and a proper dietary advice to them. REFERENCES 1. Haussinger D, Kircheis G. Hepatic encephalopathy. Schweiz Rundsch Med Prax. 2002;91: Lizardi-Cervera J, Almeda P, Guevara L, Urabe M. Hepatic encephalopathy: a review. Ann Hepatol. 2003;2: Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med. 1997;337: Blom HJ, Ferenci P, Grimm G, Yap SH, Tangerman A. The role of methanethiol in the pathogenesis of hepatic encephalopathy. Hepatology. 1991;13: Strauss E, da Costa MF. The importance of bacterial infections as precipitating factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology. 1998;45: Mahboob F. Frequency of risk factors for hepatic encephalopathy in patients of chronic liver disease. Ann King Edward Med Coll. 2003;9: Sheikh A, Ahmed SI, Naseemullah M. Aetiology of hepatic encephalopathy and importance of upper gastrointestinal bleeding
10 and infections as precipitating factors. J Rawal Med Coll. 2001;5: Khurram M, Khaar HB, Minhas Z, Javed S, Hassan Z, Hameed TA, et al. An experience of cirrhotic hepatic encephalopathy at DHQ Teaching Hospital. J Rawal Med Coll. 2001;5: Conn HO. Quantifying the severity of hepatic encephalopathy. In: Conn HO, Bircher J, editors. Hepatic encephalopathy: syndromes and therapies. West Lansing, MI: Medi-ed Press; 1993.p Lockwood AH. Early detection of hepatic encephalopathy. Neurology. 1998;6: Mashud I, Khan H, Khattak AM. Relative frequency of Hepatitis B and C viruses in patients with hepatic cirrhosis at DHQ Teaching Hospital DI Khan. J Ayub Med Coll Abbottabad. 2004;16: Marchesini G, Bianchi G, Amodio P, Salerno F, Merli M, Panella C, et al. Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology. 2001:120: Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial. Am J Dig Dis. 1978;23:
11 14. Alam I, Razaullah, Haider I, Humayun M, Taqweem MA, Nisar M. Spectrum of precipitating factors of hepatic encephalopathy in liver cirrhosis. Pak J Med Res. 2005;44: Ahmed H, Rehman M, Saeedi MI, Shah D. Factors precipitating hepatic encephalopathy in cirrhosis liver. J Postgrad Med Inst. 2001;151: Faloon WW, Evans GL. Precipitating factors in the genesis of hepatic coma. NY State J Med. 1970;70: Shaikh MA, Shaikh WM, Solangi GA, Abro H. Frequency and transmission mode of Hepatitis C virus in Northern Sindh. J Coll Physician Surg Pak. 2003;13: Fitz JG. Hepatic encephalopathy, hepatopulmonary syndromes, hepatorenal syndrome, coagulopathy and endocrine complications of liver disease. In: Feldman M, Friedman LS, Sleisenger MH, editors. Gastrointestinal and Liver Disease. 7th ed. Philadelphia: WB Saunders; 2002; Maqsood S, Saleem A, Iqbal A, Butt JA. Precipitating factors of hepatic encephalopathy: experience at Pakistan Institute Medical Sciences Islamabad. J Ayub Med Coll Abbottabad. 2006;18:57-61.
12
HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS
HEPATIC ENCEPHALOPATHY 375 ORIGINAL PROF-335 HEPATIC ENCEPHALOPATHY; PRECIPITATING FACTORS IN PATIENTS WITH CIRRHOSIS COL. DR. MANZAR ZAKARIA Classified Medical Specialist Department of Medicine DR. SYED
More informationPRECIPITATING FACTORS OF HEPATIC ENCEPHALOPATHY: EXPERIENCE AT PAKISTAN INSTITUTE OF MEDICAL SCIENCES ISLAMABAD.
PRECIPITATING FACTORS OF HEPATIC ENCEPHALOPATHY: EXPERIENCE AT PAKISTAN INSTITUTE OF MEDICAL SCIENCES ISLAMABAD. Saad Maqsood, Amer Saleem, Adeel Iqbal, Javed Aslam Butt, Department of Gastroenterolgy,
More informationSpectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis
Pakistan J. Med. Res. Vol. 44, No. 2, 2005 Spectrum of Precipitating factors of Hepatic Encephalopathy in liver cirrhosis Intekhab Alam, Razaullah, Iqbal Haider, M Humayun, M Amjad Taqweem, Muhammad Nisar
More informationOral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial
Oral Zinc Supplementation as an Adjunct Therapy in the Management of Hepatic Encephalopathy: A Randomized Controlled Trial Marcus R. Pereira A. Study Purpose Hepatic encephalopathy is a common complication
More informationEvaluation and Prognosis of Patients with Cirrhosis
Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded
More informationThe pathogenesis of hepatic encephalopathy in
Correlation between Ammonia Levels and the Severity of Hepatic Encephalopathy Janus P. Ong, MD, Anjana Aggarwal, MD, Derk Krieger, MD, Kirk A. Easley, MS, Matthew T. Karafa, MS, Frederick Van Lente, PhD,
More informationStudy of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis
Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical
More information{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis}
{ Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta Analysis} {Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, and Chuan-Yong Guo} Noor Al-Hakami, Pharm
More informationPresented by: Jean Yoo-Campbell, Matthew Konerman, Monica Konerman, Jean Yoo Campbell, Christian Gocke, Eunpi Cho Donald Lynch
Bass N.M., et. al. N Engl J Med 2010; 362:1071-1081 Presented by: Jean Yoo-Campbell, Matthew Konerman, Monica Konerman, Jean Yoo Campbell, Christian Gocke, Eunpi Cho Donald Lynch Faculty Advisor: Dr. Fred
More informationHepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room
Hepatic Encephalopathy, Hyperammonemia, and Current Treatment in ICU Room Assoc.Prof. Chan Sovandy Chairman by : Prof.So Saphy and Assoc Prof, Kim chhoung Hepatic Encephalopathy Hepatic (portal systemic
More informationCirrhosis of liver: Etiological factors, complications and prognosis
Original Article Cirrhosis of liver: Etiological factors, complications and prognosis Suhail Ahmed Almani, A. Sattar Memon, Amir Iqbal Memon, M. Iqbal Shah, M. Qasim Rahpoto, Rahim Solangi ABSTRACT OBJECTIVE:
More informationNUTRITION IN LIVER DISEASES
NUTRITION IN LIVER DISEASES 1. HEPATITIS: Definition: - Viral inflammation of liver cells. Types: a. HAV& HEV, transmitted by fecal-oral route. b. HBV & HCV, transmitted by blood and body fluids. c. HDV
More informationA CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY
A CASE OF LIVER CIRRHOSIS & HEPATIC ENCEPHALOPATHY 2 1 Mr N.N. 56 yr old male. Admitted on 22/03/02. 1 month Hx of abdominal distention, confusion, inability to concentrate and dyspnoea Grade 111. Pmx:
More informationEconomic Impact of Treatment Options for Hepatic Encephalopathy
Economic Impact of Treatment Options for Hepatic Encephalopathy Carroll B. Leevy, M.D. 1 ABSTRACT Complications of chronic liver disease, such as hepatic encephalopathy (HE), can have a substantial impact
More informationAlcoholic Hepatitis (Teacher s Guide)
Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options
More informationLiver Failure. Nora Aziz. www.3bv.org. Bones, Brains & Blood Vessels
Liver Failure Nora Aziz www.3bv.org Bones, Brains & Blood Vessels Severe deterioration in liver function Looses ability to regenerate/repair decompensated Liver extensively damaged before it fails Equal
More informationDate of preparation: March 2015. GL/XIF/0214/0011a(1)
Date of preparation: March 2015. GL/XIF/0214/0011a(1) 1 This educational programme is funded by a grant from Norgine. Norgine has no involvement in the development of the content, which is developed independently
More informationMANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
More informationBURDEN OF LIVER DISEASE IN BRAZIL
BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000
More informationLamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重
More informationCirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
More informationEnd Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012
End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis
More informationDeveloping Innovative Therapeutics for People with Orphan Liver Disease
Developing Innovative Therapeutics for People with Orphan Liver Disease PIPELINE PROGRESS AND FIRST QUARTER 2015 EARNINGS UPDATE NASDAQ: OCRX Forward-Looking Statements Certain statements in this presentation
More informationHEPATOLOGY CLERKSHIP
College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,
More informationAfter the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
More informationLiving With Hepatic Encephalopathy (HE)
Living With Hepatic Encephalopathy (HE) What is hepatic encephalopathy (HE)? HE is a condition that occurs in people with advanced cirrhosis or severe liver damage. The damaged liver cannot remove the
More informationLiver Diseases. An Essential Guide for Nurses and Health Care Professionals
Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing
More informationZahidullah Khan, Inamullah Khan, Jamal Ud Din, Fazle Subhan, Bughdad Khan, Hamza Khan Department of Medicine, Khyber Teaching Hospital, Peshawar
Spontaneous Bacterial Peritonitis ORIGINAL ARTICLE FREQUENCY OF SPONTANEOUS BACTERIAL PERITONITIS IN CIRRHOTIC PATIENTS WITH ASCITES DUE TO HEPATITIS C VIRUS AND EFFICACY OF CIPROFLOXACIN IN ITS TREATMENT
More informationa series of fact sheets written by experts in the field of liver disease HCV DISEASE PROGRESSION
www.hcvadvocate.org HCSP FACT SHEET Symptoms & Complications of Cirrhosis Foreword After many years of infection with hepatitis C the liver can become severely scarred. The process starts with inflammation
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationDIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY
ORIGINAL PAPER 373 DIETARY THERAPY IMPACT FOR CIRRHOTIC PATIENTS WITH HEPATIC ENCEPHALOPATHY Adriana Teiuşanu 1,, Mirela Ionescu 1, S. Gologan 1, Adriana Stoicescu 1, M. Andrei 1, T. Nicolaie 1, M. Diculescu
More informationResults Demographic profile of these children is shown in Table I.
Prevalence of Antibody to Hepatitis C Virus in Pakistani Thalassaemics by Particle Agglutination Test Utilizing C 200 and C 22-3 Viral Antigen Coated Particles Pages with reference to book, From 269 To
More informationHepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs
Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationLIVER TRANSPLANTATION IN ALAGILLE SYNDROME
LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic
More informationThe Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome
Biomedical & Pharmacology Journal Vol. 6(2), 259-264 (2013) The Initial and 24 h (After the Patient Rehabilitation) Deficit of Arterial Blood Gases as Predictors of Patients Outcome Vadod Norouzi 1, Ali
More information190.33 - Hepatitis Panel/Acute Hepatitis Panel
190.33 - Hepatitis Panel/Acute Hepatitis Panel This panel consists of the following tests: Hepatitis A antibody (HAAb), IgM antibody; Hepatitis B core antibody (HBcAb), IgM antibody; Hepatitis B surface
More informationPREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto
PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized
More informationCOMPLICATIONS OF CIRRHOSIS COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST. Philip C. Delich, M.D.
1 COMPLICATIONS OF CIRRHOSIS OBSERVATIONS OF AN AGING HEPATOLOGIST COMPLICATIONS OF CIRRHOSIS Philip C. Delich, M.D. Faculty Disclosure Dr. Delich has indicated that he does not have any relevant financial
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More informationINSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN)
E:/Biomedica/New Journal 2004/Bio-11.doc (A) INSULIN REQUIREMENT IN DIABETIC PATIENTS WITH CHRONIC RENAL FAILURE DUE TO DIABETIC NEPHROPATHY (DN) KAMRAN RASHID, KHALIL UR REHMAN, M. SAEED ANWER AAEISHA
More informationThe rate of failure to thrive among children aged 2 months - 5 years in Kanaan sub-district / Diyala province
The rate of failure to thrive among children aged 2 months - 5 years in Kanaan sub-district / Diyala province Mehdi SH. Al-Zuheiry (M.B.Ch.B., F.I.C.M.S.Ped.) College of Medicine-Diyala University Background:
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationAcute Pancreatitis. Questionnaire. if yes: amount (cigarettes/day): since when (year): Drug consumption: yes / no if yes: type of drug:. amount:.
The physical examination has to be done AT ADMISSION! The blood for laboratory parameters has to be drawn AT ADMISSION! This form has to be filled AT ADMISSION! Questionnaire Country: 1. Patient personal
More informationPEER REVIEW HISTORY ARTICLE DETAILS VERSION 1 - REVIEW
PEER REVIEW HISTORY BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf)
More informationHepatic Encephalopathy (Brain Disorder Secondary to Liver Disease) Basics
Hepatic Encephalopathy (Brain Disorder Secondary to Liver Disease) Basics OVERVIEW Hepatic refers to the liver; encephalopathy is the medical term for any disorder of the brain Disorder affecting the central
More informationHEPATIC ENCEPHALOPATHY
HEPATIC ENCEPHALOPATHY Jan Albrecht Department of Neurotoxicology, Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland Brussels, July 14, 2009 DEFINITIONS: - HEPATIC ENCEPHALOPATHY (HE)
More informationEarly Liver Transplantation in Patients with Acute Hepatitis
Introduction Alcohol abuse is the leading cause of liver disease in Western countries, and an estimated 50% of the population above 18 years-old in the United States drinks alcohol. There are three overlapping
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationCARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS
LUCIAN BLAGA UNIVERSITY OF SIBIU VICTOR PAPILIAN FACULTY OF MEDICINE CARDIOVASCULAR DYSFUNCTION IN LIVER CIRRHOSIS Ph.D. THESIS SUMMARY COORDINATOR: PROF.DR. MANIŢIU IOAN Ph.D. STUDENT: LORENA MĂRIEŞ SIBIU
More informationAUBAGIO (teriflunomide) oral tablet
AUBAGIO (teriflunomide) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationManagement of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok
Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US
More informationNORD Guides for Physicians #1. Physician s Guide to. Tyrosinemia. Type 1
NORD Guides for Physicians #1 The National Organization for Rare Disorders Physician s Guide to Tyrosinemia Type 1 The original version of this booklet was made possible by donations in honor of Danielle
More informationThe most serious symptoms of this stage are:
The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying
More informationLiver Function Tests. Dr Stephen Butler Paediatric Advance Trainee TDHB
Liver Function Tests Dr Stephen Butler Paediatric Advance Trainee TDHB Introduction Case presentation What is the liver? Overview of tests used to measure liver function RJ 10 month old European girl
More informationCirrhosis and Ascites. Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961
Cirrhosis and Ascites Thomas S. Foster, Pharm.D. Integrated Therapeutics PHR 961 Overview Liver weighs about 3 pounds and is the largest organ in the body. It is located in the upper right side of the
More informationA Guide for Successfully Completing the Group Disability Insurance Evidence of Insurability Form
A Guide for Successfully Completing the Group Disability Insurance Evidence of Insurability Form Mutual of Omaha appreciates the opportunity to provide you with valuable income protection. So that we can
More informationThe sooner the better
The sooner the better A guide to MARS the liver support therapy Liver failure and MARS therapy Developing acute liver failure or deteriorating from a chronic liver disease, thousands of people are enlisted
More informationNational Health Burden of CLD in Italy
National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /
More informationContents. 3. Anaphylaxis in Children... 21 Causes of Anaphylaxis 21 Symptoms 22 Signs 23 Treatment 24 Patient Education 25
Contents 1. Asthma in Children... 1 Asthma 1 Definition 1 Etiology 2 Risk Factors 2 Symptoms 3 Signs 3 Investigations 4 Classification of Asthma 4 Management of Asthma 6 Types of Inhalation Devices Available
More informationCIRRHOSIS REFERRAL & MANAGEMENT GUIDELINES for the Southern Adelaide Local Health Network (SALHN)
CIRRHOSIS REFERRAL & MANAGEMENT GUIDELINES for the Southern Adelaide Local Health Network (SALHN) Cirrhosis is severe scarring of the liver and can be diagnosed with ultrasound or CT or with clinical signs
More informationCHOC CHILDREN SUROLOGY CENTER. Constipation
Constipation What is constipation? Constipation is a condition in which a person has uncomfortable or infrequent bowel movements. Generally, a person is considered to be constipated when bowel movements
More informationLiver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
More informationThings You Don t Want to Miss in Multiple Myeloma
Things You Don t Want to Miss in Multiple Myeloma Sreenivasa Chandana, MD, PhD Attending Hematologist and Medical Oncologist West Michigan Cancer Center Assistant Professor, Western Michigan University
More informationAlbumin. Prothrombin time. Total protein
Hepatitis C Fact Sheet February 2016 www.hepatitis.va.gov Laboratory Tests and Hepatitis If you have hepatitis C, your doctor will use laboratory tests to about learn more about your individual hepatitis
More informationKnowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan
{189} ORIGINAL RESEARCH Knowledge about Post-exposure Prophylaxis for Hepatitis B Virus among Dentists and Dental Students in Pakistan Zohaib Ahmed 1 Umber Zahra 2 Nasir Saleem 3 1,2 BDS. House Officer.
More informationRecommendations 8/14/2014. Hepatitis C Clinical Approach Primary Care. Purpose of Presentation. HCV Prevalence Year of Birth
Hepatitis C Clinical Approach Primary Care Dr. Vicki L. MIt McIntyre, FNP Tucson Gastroenterology Specialists Tucson, Arizona University of Phoenix Lead Faculty, Department of Nursing Tucson, Arizona Purpose
More informationHow To Know If Low Protein Diet Is Beneficial For Kidney Health
Protein Intake and Diabetic Kidney Disease Robert C. Stanton Joslin Diabetes Center 1/Serum Creatinine Plot Low Protein Protects in Renal Ablation Model 24% Protein Diet 6% Protein Diet Right Nephrectomy
More informationInsulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both.
Diabetes Definition Diabetes is a chronic (lifelong) disease marked by high levels of sugar in the blood. Causes Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused
More informationINITIATING ORAL AUBAGIO (teriflunomide) THERAPY
FOR YOUR PATIENTS WITH RELAPSING FORMS OF MS INITIATING ORAL AUBAGIO (teriflunomide) THERAPY WARNING: HEPATOTOXICITY AND RISK OF TERATOGENICITY Severe liver injury including fatal liver failure has been
More informationUCLA Asian Liver Program
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
More information1MFBTF GJMM PVU GPSNT BOE GBY 'PSNT XJMM CF TJHOFE BU ZPVS BQQPJOUNFOU
CELL PHONE: PATIENT HISTORY FORM - CONFIDENTIAL DATE: PATIENT: (LAST NAME) (FIRST NAME) (Ml) (NICKNAME) DOB: Primary Physician/ Family Doctor: Phone: Past Medical History (Click all that apply) High blood
More informationOMG my LFT s! How to Interpret and Use Them. OMG my LFT s! OMG my LFT s!
How to Interpret and Use Them René Romero, M.D. Clinical Director, Pediatric Hepatology CPG Gastroenterology, Hepatology and Nutrition Emory University School of Medicine Objectives Understand the anatomy
More informationAlbumin (serum, plasma)
Albumin (serum, plasma) 1 Name and description of analyte 1.1 Name of analyte Albumin (plasma or serum) 1.2 Alternative names None (note that albumen is a protein found in avian eggs) 1.3 NLMC code 1.4
More informationScience Highlights. To PSA or not to PSA: That is the Question.
Science Highlights June 2012 by Ann A. Kiessling, PhD at the To PSA or not to PSA: That is the Question. The current raucous debate over the commonly used PSA blood test to screen for prostate cancer,
More informationHow To Determine The Prevalence Of Microalbuminuria
Research Journal of Pharmaceutical, Biological and Chemical Sciences Prevalence of Microalbuminuria in relation to HbA1c among known Type2 Diabetic Patients in Puducherry population Muraliswaran P 1 *,
More informationRecommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965
Recommendations for the Identification of Chronic Hepatitis C virus infection Among Persons Born During 1945-1965 MMWR August 17, 2012 Prepared by : The National Viral Hepatitis Technical Assistance Center
More informationEfficacy of Rifaximin in Prevention of Recurrence of Hepatic Encephalopathy in Patients with Cirrhosis of Liver
ORIGINAL ARTICLE Efficacy of Rifaximin in Prevention of Recurrence of Hepatic Encephalopathy in Patients with Cirrhosis of Liver Bushra Ali, Yasir Abbas Zaidi, Altaf Alam and Hafiz Sohail Anjum ABSTRACT
More informationEpidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
More informationRivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE)
Rivaroxaban: Prescribing Guidance for the treatment of provoked venous thromboembolism (VTE) Amber Drug Level 2 Leeds We have started your patient on rivaroxaban for the treatment of provoked VTE (deep
More informationQuality Scorecard overall heart attack care overall heart failure overall pneumonia care overall surgical infection rate patient safety survival
Quality Scorecard s are required to report quality statistics to the s for Medicare and Medicaid Services (CMS) and the Department of Health (DOH). This information is made available at www.hospitalcompare.hhs.gov
More informationrifaximin 550mg film-coated tablets (Targaxan ) SMC No. (893/13) Norgine Pharmaceuticals Ltd
rifaximin 550mg film-coated tablets (Targaxan ) SMC No. (893/13) Norgine Pharmaceuticals Ltd 09 August 2013 The Scottish Medicines Consortium (SMC) has completed its assessment of the above product and
More informationhttp://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx
http://nurse practitioners and physician assistants.advanceweb.com/features/articles/alcohol Abuse.aspx Alcohol Abuse By Neva K.Gulsby, PA-C, and Bonnie A. Dadig, EdD, PA-C Posted on: April 18, 2013 Excessive
More informationComplications of Chronic Liver Disease
Complications of Chronic Liver Disease By Rima A. Mohammad, Pharm.D., BCPS Reviewed by Paulina Deming, Pharm.D.; Marisel Segarra-Newnham, Pharm.D., MPH, FCCP, BCPS; and Kelly S. Bobo, Pharm.D., BCPS Learning
More informationUrinary Tract Infection in Stone Patients and in Patients with Indwelling Urethral Catheters
Urinary Tract Infection in Stone Patients and in Patients with Indwelling Urethral Catheters Pages with reference to book, From 254 To 258 Farakh A. Khan, Salman H. Siddiqui, Nasreen Akhtar ( Department
More informationTreatment of Acute Hepatitis C
Management of Patients with Viral Hepatitis, Paris, 2004 Treatment of Acute Hepatitis C Michael P. Manns, Andrej Potthoff, Elmar Jaeckel, Heiner Wedemeyer Hepatitis C Virus (HCV) infection is a common
More informationOmega-3 fatty acids improve the diagnosis-related clinical outcome. Critical Care Medicine April 2006;34(4):972-9
Omega-3 fatty acids improve the diagnosis-related clinical outcome 1 Critical Care Medicine April 2006;34(4):972-9 Volume 34(4), April 2006, pp 972-979 Heller, Axel R. MD, PhD; Rössler, Susann; Litz, Rainer
More informationLife Insurance Application Form
Life Insurance Application Form INSTRUCTION To be completed by all applicants PERSONAL DETAILS Surname First name Middle name Sex Female Male Marital status (please tick) Single Married Other Current residential
More informationPATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
More informationJune 11, 2015 Tim Halterman
June 11, 2015 Tim Halterman Defini&on Histologic change + loss of liver function Derives from Greek word kirrhos meaning yellow, tawny First named by Rene Laennec in 1819 Laennec s cirrhosis=alcoholic
More informationPreoperative Laboratory and Diagnostic Studies
Preoperative Laboratory and Diagnostic Studies Preoperative Labratorey and Diagnostic Studies The concept of standardized testing in all presurgical patients regardless of age or medical condition is no
More informationNon-alcoholic fatty liver disease: Prognosis and Treatment
Non-alcoholic fatty liver disease: Prognosis and Treatment Zachary Henry, M.D. Assistant Professor UVA Gastroenterology & Hepatology October 28, 2015 Overview Case Presentation Prognosis Effects of fibrosis
More informationlength of stay in hospital, sex, marital status, discharge status and diagnostic categories. Mean age and mean length of stay were compared for the
Clinical and Demographic Characteristics of Psychiatric Inpatients admitted via Emergency and Non-Emergency routes at a University Hospital in Pakistan E.U. Syed,R. Atiq ( Departments of Psychiatry, Aga
More informationMortality of patients with alcoholic liver disease admitted to critical care: a systematic review
The Intensive Care Society 2012 Mortality of patients with alcoholic liver disease admitted to critical care: a systematic review S Flood, A Bodenham, P Jackson This review examined the burden of alcohol-related
More informationHEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis
HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School
More information1333 Plaza Blvd, Suite E, Central Point, OR 97502 * www.mountainviewvet.net
1333 Plaza Blvd, Suite E, Central Point, OR 97502 * www.mountainviewvet.net Diabetes Mellitus (in cats) Diabetes, sugar Affected Animals: Most diabetic cats are older than 10 years of age when they are
More informationAtrial fibrillation: medicines to help reduce your risk of a stroke what are the options?
Patient decision aid Atrial fibrillation: medicines to help reduce your risk of a stroke what are the options? http://guidance.nice.org.uk/cg180/patientdecisionaid/pdf/english Published: June 2014 About
More informationTransmission of HCV in the United States (CDC estimate)
Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong
More informationATTENDING PHYSICIAN S STATEMENT CRITICAL ILLNESS (CHRONIC LIVER DISEASE / END STAGE LIVER FAILURE)
ATTENDING PHYSICIAN S STATEMENT CRITICAL ILLNESS (CHRONIC LIVER DISEASE / END STAGE LIVER FAILURE) Name NRIC Number Policy Number Claim Number (For internal use) The abovenamed is insured with us against
More information